No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Is Cytek Biosciences (NASDAQ:CTKB) A Risky Investment?
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Crude Oil Gains 1%; Chicago PMI Falls In December
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
Cytek Biosciences Announces $50M Stock Repurchase Program for 2025
Express News | Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025